# Sulfasalazine

## Salazine 500mg enteric coated

| TAH Drug Code      | [OSAL5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSAL5)                                                                                                                                                                                                                                                                                                                                                                                                                              |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Ulcerative Colitis, Crohnâ€™s disease, Rheumatoid Arthritis.                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Inflammatory bowel disease including Crohn's disease, ulcerative colitis: Adult moderate attacks: 2 tables TID-QID. Severe attacks: 2-4 TABTID-QID. Children: 40-60 mg/kg/day in 3-6 doses. Maintenance: Adult 2 tablets BID-TID. Children 20-30 mg/kg/day in 3-6 divided doses. RA : 2 tablets BID. Child (Juvenile chronic arthritis), no enough information.                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Contraindications  | Patients allergic to sulfonamides or acetylsalicylic acid medications. Acute intermittent porphyria.                                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | Nausea, anorexia, raised temp; erythema & pruritus; headache. Rarely, hematological, GI, CNS, renal, dermatological reactions. Dermatologic: Pruritus (3% to 4% ), Rash (3% to 13% ) Gastrointestinal: Abdominal pain (8% ), Indigestion (13% to 33% ), Loss of appetite (33% ), Nausea (19% to 33% ), Stomatitis (4% ), Vomiting (8% to 33% ) Neurologic: Dizziness (4% ), Headache (9% to 33% ) Renal: Discolored urine Reproductive: Oligozoospermia, Reversible (33% ) Other: Fever (3% to 5% ) |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sulfasalazine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                        |

